Opioid discontinuation as an institutional mandate: Questions and answers on why we wrote to the Centers for Disease Control and Prevention

被引:0
|
作者
Kertesz, Stefan G. [1 ]
Satel, Sally L. [2 ]
DeMicco, James [3 ]
Dart, Richard C. [4 ]
Alford, Daniel P. [5 ,6 ]
机构
[1] Univ Alabama Birmingham, Sch Med, Birmingham Vet Affairs Med Ctr, 1717 11th Ave South,MT608, Birmingham, AL 35205 USA
[2] Yale Univ, Sch Med, Amer Enterprise Inst, Washington, DC USA
[3] Long Isl Univ, Coll Pharm, Brooklyn, NY USA
[4] Denver Hlth & Hosp Author, Denver, CO USA
[5] Boston Univ, Sch Med, Clin Addict Res & Educ CARE Unit, Boston, MA 02118 USA
[6] Boston Med Ctr, Boston, MA USA
关键词
CHRONIC PAIN; OVERDOSE; RISK;
D O I
10.1080/08897077.2019.1613830
中图分类号
R194 [卫生标准、卫生检查、医药管理];
学科分类号
摘要
引用
收藏
页码:4 / 6
页数:3
相关论文
共 38 条
  • [21] Opioid prescribing practices at hospital discharge for surgical patients before and after the Centers for Disease Control and Prevention’s 2016 opioid prescribing guideline
    Erica Langnas
    Andrew Bishara
    Rhiannon Croci
    Rosa Rodriguez-Monguio
    Elizabeth C. Wick
    Catherine L. Chen
    Zhonghui Guan
    BMC Anesthesiology, 22
  • [22] Comparison of Opioids Prescribed for Patients at Risk for Opioid Misuse Before and After Publication of the Centers for Disease Control and Prevention's Opioid Prescribing Guidelines
    Scherrer, Jeffrey F.
    Tucker, Jane
    Salas, Joanne
    Zhang, Zidong
    Grucza, Richard
    JAMA NETWORK OPEN, 2020, 3 (12)
  • [23] Management of Adult Syphilis: Key Questions to Inform the 2015 Centers for Disease Control and Prevention Sexually Transmitted Diseases Treatment Guidelines
    Ghanem, Khalil G.
    CLINICAL INFECTIOUS DISEASES, 2015, 61 : S818 - S836
  • [24] Management of Adult Syphilis: Key Questions to Inform the 2021 Centers for Disease Control and Prevention Sexually Transmitted Infections Treatment Guidelines
    Tuddenham, Susan
    Ghanem, Khalil G.
    CLINICAL INFECTIOUS DISEASES, 2022, 74 (SUPPL 2) : S127 - S133
  • [25] Challenges with Implementing the Centers for Disease Control and Prevention Opioid Guideline: A Consensus Panel Report (vol 20, pg 724, 2019)
    Kroenke, Kurt
    Alford, Daniel P.
    Argoff, Charles
    Canlas, Bernard
    Covington, Edward
    Frank, Joseph W.
    Haake, Karl J.
    Hanling, Steven
    Hooten, Michael
    Kertesz, Stefan G.
    Kravitz, Richard L.
    Krebs, Erin E.
    Stanos, Steven P., Jr.
    Sullivan, Mark
    PAIN MEDICINE, 2022, 23 (09) : 1636 - 1636
  • [26] Why "good enough" is not good enough: scientific data, not supply chain deficiencies, should be driving Centers for Disease Control and Prevention recommendations
    Morgan, Elizabeth A.
    Rodriguez, Diana
    AMERICAN JOURNAL OF OBSTETRICS & GYNECOLOGY MFM, 2020, 2 (03)
  • [28] Evaluation of the centers for disease control and prevention's recommendations regarding routine testing for human immunodeficiency virus by an inpatient service: Who are we missing?
    Greenwald, JL
    Rich, CA
    Bessega, S
    Posner, MA
    Maeda, JL
    Skolnik, PR
    MAYO CLINIC PROCEEDINGS, 2006, 81 (04) : 452 - 458
  • [29] The Centers for Disease Control and Prevention opioid guideline revisions and pharmacy practice: An opinion of the American College of Clinical Pharmacy Pain and Palliative Care Practice and Research Network
    Emshoff, Jessica B.
    Theken, Katherine N.
    Juba, Katherine M.
    Trombetta, Dominick P.
    Denham, Hannah
    Carr, Megan
    Love, Nancy
    Page, Mackenzie
    Uebbing, Emily
    Lehr, Victoria Tutag
    JOURNAL OF THE AMERICAN COLLEGE OF CLINICAL PHARMACY, 2025, 8 (03): : 224 - 231
  • [30] Surveillance for Ventilator-Associated Pneumonia: Can We Apply Centers for Disease Control and Prevention National Healthcare Safety Network 2013 Definitions for All Settings?
    Metan, Gokhan
    Zengin, Humeyra
    Cinar, Burcu
    Aytac, Hanife
    Hayran, Mutlu
    Unal, Serhat
    INFECTION CONTROL AND HOSPITAL EPIDEMIOLOGY, 2016, 37 (09): : 1125 - 1127